Mammalian Cells – BiotechReality – Information Intelligence System for Biopharma

A breakthrough study has revealed that researchers at the Centre for Genomic Regulation (CRG) have designed an artificial intelligence (AI) system to generate synthetic DNA molecules that will allow them to optimize gene expression in healthy mammalian cells. The research, which appeared in the journal Cell, is a breakthrough in the science of generative biology. The computer program forecasts individual strands of DNA building blocks (A, T, C, and G) needed to create desired patterns of gene expression in various types of cells. Researchers constructed these AI-designed DNA pieces and inserted them into cells, where they could be switched on and off. In one experiment, AI-designed DNA fragments were inserted into mouse blood cells. The fragments integrated into the host genome and made a gene turn on for making a fluorescent protein in certain cells but had no effect on the others' gene expression profiles. This indicates the possibility of highly specific gene therapy, where there is very precise control of a gene's activity in certain cells or tissues. The AI model was trained on the outcomes of thousands of blood formation experiments specifically analyzing enhancers (DNA sequences that enhance gene activity) and transcription factors (proteins that regulate gene expression). The massive dataset allowed the AI to learn the complex interplay between DNA sequence and gene expression. The study also revealed novel information about the complex relationship between enhancers and transcription factors. Of special interest, scientists discovered that certain groups of transcription factors can repress the activity of genes, a function that is opposite to existing postulates. This research is an important step in our ability to instruct cells and guide their activity with unprecedented accuracy. The ability to engineer DNA that precisely controls gene expression holds deep implications for basic research, as well as for possible treatments. Source: Centre for Genomic Regulation (CRG)Journal Reference: Robert Frömel, Julia Rühle, Aina Bernal Martinez, Chelsea Szu-Tu, Felix Pacheco Pastor, Rosa Martinez-Corral, Lars Velten. Design principles of cell-state-specific enhancers in hematopoiesis. Cell, 2025 DOI: 10.1016/j.cell.2025.04.017 Last Modified:

Tag: Mammalian Cells

AI Achieves First Gene Control in Mammalian Cells via Designed DNA

Areas Covered

Discover More

GSK Secures Japan Orphan Drug Designation for Risvutatug Rezetecan in Small-Cell Lung Cancer

Pfizer’s Talzenna + Xtandi Delivers Proven rPFS Breakthrough in HRR-Mutated mCSPC

Eli Lilly Declares Powerful 2% A1C Reduction and 17% Weight Loss in Landmark Phase 3 Trial Results of Retatrutide

ICOTYDE FDA Approval: J&J’s First-Line Oral Peptide Breakthrough for Plaque Psoriasis Treatment

Atirmociclib Phase 2 Breakthrough: Pfizer Declares Powerful Results for Metastatic Breast Cancer Treatment

EBGLYSS (lebrikizumab-lbkz) Delivers Remarkable Phase 3 Results for Pediatric Atopic Dermatitis Treatment